StonvexLoading…
StonvexStonvexStonvexCore line items from DRS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.65B | $3.23B | $2.83B | $2.69B |
Operating Income | $348.00M | $293.00M | $231.00M | $561.00M |
Net Income | $278.00M | $213.00M | $168.00M | $405.00M |
EPS (Diluted) | $1.03 | $0.80 | $0.64 | $1.88 |
Total Assets | $4.49B | $4.18B | $3.92B | $3.68B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $647.00M | $598.00M | $467.00M | $306.00M |
Free Cash Flow OCF − CapEx | $227.00M | $186.00M | $145.00M | $-32.00M |
Shares Outstanding | 265.82M | 265.06M | 262.53M | 260.23M |